Medical News |
- Nurse/health worker-led intervention improves CVD risk profile
- ‘DIDO’ time rarely meets recommended limit
- Fatty acid supplementation reduces ventricular arrhythmia-related events
- Fatty acid supplementation reduces ventricular arrhythmia-related events
- Elevated adiponectin decreases PAD risk in women
- BD, schizophrenia patients show altered neurotransmitter transporter expression
- Six rare CNVs strongly linked to schizophrenia
- Full prescription coverage improves adherence, reduces adverse outcomes, spending
- One in ten PCI patients readmitted within 30 days
- Dalcetrapib raises HDL cholesterol in diabetes, the metabolic syndrome
- Urinary F<sub>2</sub>-isoprostanes may predict diabetes risk
- Ezetimibe reduces atherogenic small, dense LDL cholesterol
- Dietary fiber link to diverticulosis risk refuted
- sVAP-1 identified as a cardiovascular risk factor
- Ezetimibe reduces atherogenic small, dense LDL cholesterol
- Comorbid migraine linked to poorer outcomes in BD patients
- Regional thalamic volume deficits identified in early-onset psychosis
- Urgent-access TIA clinics beat hospitalization for cost effectiveness
- IV iron may reduce thromboembolism risk in chemotherapy patients
| Nurse/health worker-led intervention improves CVD risk profile Posted: 29 Nov 2011 04:00 PM PST An intervention delivered by a nurse practitioner/community health worker team improves the risk profile of cardiovascular disease patients more than an enhanced usual care program does, researchers say. |
| ‘DIDO’ time rarely meets recommended limit Posted: 29 Nov 2011 04:00 PM PST The door-in to door-out time for patients being transferred to another hospital for percutaneous coronary intervention in the USA rarely meets the recommended 30 minutes, researchers say. |
| Fatty acid supplementation reduces ventricular arrhythmia-related events Posted: 29 Nov 2011 04:00 PM PST Low doses of n-3 fatty acids reduce the risk for ventricular arrhythmia-related events in post-myocardial infarction patients with diabetes, research shows. |
| Fatty acid supplementation reduces ventricular arrhythmia-related events Posted: 29 Nov 2011 04:00 PM PST Low doses of n-3 fatty acids reduce the risk for ventricular arrhythmia-related events in post-myocardial infarction patients with diabetes, research shows. |
| Elevated adiponectin decreases PAD risk in women Posted: 29 Nov 2011 04:00 PM PST Women with elevated adiponectin levels may be at a decreased risk for peripheral artery disease, study findings indicate. |
| BD, schizophrenia patients show altered neurotransmitter transporter expression Posted: 29 Nov 2011 04:00 PM PST Results from a postmortem study show that individuals with bipolar disorder and schizophrenia have significantly altered expression of glutamate and dopamine transporters in the frontal cortex compared with mentally healthy individuals. |
| Six rare CNVs strongly linked to schizophrenia Posted: 29 Nov 2011 04:00 PM PST Results from a UK study provide strong support for an association between schizophrenia and six rare copy number variants. |
| Full prescription coverage improves adherence, reduces adverse outcomes, spending Posted: 28 Nov 2011 04:00 PM PST A full prescription coverage medical insurance plan after myocardial infarction improves medication adherence, decreases risk for vascular events, and reduces patient spending without increasing overall health costs, an analysis suggests. |
| One in ten PCI patients readmitted within 30 days Posted: 28 Nov 2011 04:00 PM PST Nearly one in ten patients who undergo percutaneous coronary intervention are readmitted within 30 days, a study has found. |
| Dalcetrapib raises HDL cholesterol in diabetes, the metabolic syndrome Posted: 28 Nov 2011 04:00 PM PST Dalcetrapib is effective at raising high-density lipoprotein cholesterol among patients with Type 2 diabetes and/or the metabolic syndrome who are at significant risk for cardiovascular events, report researchers. |
| Urinary F<sub>2</sub>-isoprostanes may predict diabetes risk Posted: 28 Nov 2011 04:00 PM PST Urinary F2-isoprostanes may be useful for identifying individuals at high risk for Type 2 diabetes, suggest study findings. |
| Ezetimibe reduces atherogenic small, dense LDL cholesterol Posted: 28 Nov 2011 04:00 PM PST Treatment with ezetimibe alone or in combination with simvastatin lowers the concentration of small, dense low-density lipoprotein cholesterol particles in patients with Type 2 diabetes, research shows. |
| Dietary fiber link to diverticulosis risk refuted Posted: 28 Nov 2011 04:00 PM PST Research published in the journal Gastroenterology challenges the belief that a high-fiber diet protects against the development of diverticulosis. |
| sVAP-1 identified as a cardiovascular risk factor Posted: 28 Nov 2011 04:00 PM PST Soluble vascular adhesion protein-1 activity correlates with cardiovascular risk factors and early atherosclerotic manifestations, report researchers. |
| Ezetimibe reduces atherogenic small, dense LDL cholesterol Posted: 28 Nov 2011 04:00 PM PST Treatment with ezetimibe alone or in combination with simvastatin lowers the concentration of small, dense low-density lipoprotein cholesterol particles in patients with Type 2 diabetes, research shows. |
| Comorbid migraine linked to poorer outcomes in BD patients Posted: 28 Nov 2011 04:00 PM PST Patients with bipolar disorder who also suffer from migraine have poorer outcomes than those who do not experience such headaches, results from a Brazilian study suggest. |
| Regional thalamic volume deficits identified in early-onset psychosis Posted: 28 Nov 2011 04:00 PM PST Results from a Spanish study of adolescents with early-onset psychosis show that thalamic volume deficits are most pronounced in the right anterior mediodorsal and posterior pulvinar regions. |
| Urgent-access TIA clinics beat hospitalization for cost effectiveness Posted: 28 Nov 2011 04:00 PM PST Widespread availability of urgent-access transient ischemic attack clinics avoids the need for hospitalization, which benefits only a very small proportion of patients, show the findings of a decision analysis. |
| IV iron may reduce thromboembolism risk in chemotherapy patients Posted: 28 Nov 2011 04:00 PM PST Administering intravenous iron may reduce the risk for venous thromboembolism in patients with chemotherapy induced anemia, US study findings suggest. |
| You are subscribed to email updates from MedWire Medical News Combined Feed To stop receiving these emails, you may unsubscribe now. | Email delivery powered by Google |
| Google Inc., 20 West Kinzie, Chicago IL USA 60610 | |
No comments:
Post a Comment